AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54

Authors: HAMMOND LA ECKARDT JR GANAPATHI R BURRIS HA RODRIGUEZ GA ECKHARDT SG ROTHENBERG ML WEISS GR KUHN JG HODGES S VONHOFF DD ROWINSKY EK
Citation: La. Hammond et al., A PHASE-I AND TRANSLATIONAL STUDY OF SEQUENTIAL ADMINISTRATION OF THETOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITORS TOPOTECAN AND ETOPOSIDE, Clinical cancer research, 4(6), 1998, pp. 1459-1467

Authors: ECKHARDT SG BAKER SD ECKARDT JR BURKE TG WARNER DL KUHN JG RODRIGUEZ G FIELDS S THURMAN A SMITH L ROTHENBERG ML WHITE L WISSEL P KUNKA R DEPEE S LITTLEFIELD D BURRIS HA VONHOFF DD ROWINSKY EK
Citation: Sg. Eckhardt et al., PHASE-I AND PHARMACOKINETIC STUDY OF GI147211, A WATER-SOLUBLE CAMPTOTHECIN ANALOG, ADMINISTERED FOR 5 CONSECUTIVE DAYS EVERY 3 WEEKS, Clinical cancer research, 4(3), 1998, pp. 595-604

Authors: ECKHARDT SG BAKER SD ECKARDT JR BURKE TG WARNER DL KUHN JG RODRIGUEZ G FIELDS S THURMAN A SMITH L ROTHENBERG ML WHITE L WISSEL P KUNKA R DEPEE S LITTLEFIELD D BURRIS HA VONHOFF DD ROWINSKY EK
Citation: Sg. Eckhardt et al., PHASE-I AND PHARMACOKINETIC STUDY OF GI147211, A WATER-SOLUBLE CAMPTOTHECIN ANALOG, ADMINISTERED FOR 5 CONSECUTIVE DAYS EVERY 3 WEEKS, Clinical cancer research, 4(3), 1998, pp. 595-604

Authors: ROTHENBERG ML SHARMA A WEISS GR VILLALONACALERO MA ECKARDT JR AYLESWORTH C KRAYNAK MA RINALDI DA RODRIGUEZ GI BURRIS HA ECKHARDT SG STEPHENS CD FORRAL K NICOL SJ VONHOFF DD
Citation: Ml. Rothenberg et al., PHASE-I TRIAL OF PACLITAXEL AND GEMCITABINE ADMINISTERED EVERY 2 WEEKS IN PATIENTS WITH REFRACTORY SOLID TUMORS, Annals of oncology, 9(7), 1998, pp. 733-738

Authors: RAYMOND E BURRIS HA ROWINSKY EK ECKARDT JR RODRIGUEZ G SMITH L WEISS G VONHOFF DD
Citation: E. Raymond et al., TOPOTECAN IN COMBINATION WITH CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED NON-SMALL-CELL LUNG-CARCINOMA - A PHASE-I STUDY, Annals of oncology, 9, 1998, pp. 266-266

Authors: ROYCE M PAZDUR R RODRIGUEZ GM RINALDI DA PATT YZ BURRIS HA
Citation: M. Royce et al., PHASE-II STUDY OF DOCETAXEL IN PATIENTS WITH UNRESECTABLE CHOLANGIOCARCINOMA, Annals of oncology, 9, 1998, pp. 377-377

Authors: BAKER SD RAVDIN P AYLESWORTH C SMETZER L BRUNO R VERNILLET L PAZDUR R DOYLE G HAMMERSHAIMB L HOOKER E BURRIS HA ECKHARDT SG JOHNSON T KRAYNAK M HAMMOND L RODRIGUEZ G WEISS G ROWINSKY EK
Citation: Sd. Baker et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF DOCETAXEL IN CANCER-PATIENTS WITH LIVER DYSFUNCTION DUE TO MALIGNANCIES, Annals of oncology, 9, 1998, pp. 388-388

Authors: HAINSWORTH JD BURRIS HA ERLAND JB THOMAS M GRECO FA
Citation: Jd. Hainsworth et al., PHASE-I TRIAL OF DOCETAXEL ADMINISTERED BY WEEKLY INFUSION IN PATIENTS WITH ADVANCED REFRACTORY CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2164-2168

Authors: SCHILSKY RL HOHNEKER J RATAIN MJ JANISCH L SMETZER L LUCAS VS KHOR SP DIASIO R VONHOFF DD BURRIS HA
Citation: Rl. Schilsky et al., PHASE-I CLINICAL AND PHARMACOLOGICAL STUDY OF ENILURACIL PLUS FLUOROURACIL IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 16(4), 1998, pp. 1450-1457

Authors: VALERO V JONES SE VONHOFF DD BOOSER DJ MENNEL RG RAVDIN PM HOLMES FA RAHMAN Z SCHOTTSTAEDT MW ERBAN JK ESPARZAGUERRA L EARHART RH HORTOBAGYI GN BURRIS HA
Citation: V. Valero et al., A PHASE-II STUDY OF DOCETAXEL IN PATIENTS WITH PACLITAXEL-RESISTANT METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3362-3368

Authors: BRUNO R HILLE D RIVA A VIVIER N HUINNINK WWTB VANOOSTEROM AT KAYE SB VERWEIJ J FOSSELLA FV VALERO V RIGAS JR SEIDMAN AD CHEVALLIER B FUMOLEAU P BURRIS HA RAVCLIN PM SHEINER LB
Citation: R. Bruno et al., POPULATION PHARMACOKINETICS PHARMACODYNAMICS OF DOCETAXEL IN PHASE-IISTUDIES IN PATIENTS WITH CANCER/, Journal of clinical oncology, 16(1), 1998, pp. 187-196

Authors: BURRIS HA VOGEL CL CASTRO D MISHRA L SCHWARZ M SPENCER S OAKES DD KOREY A ORENBERG EK
Citation: Ha. Burris et al., INTRATUMORAL CISPLATIN EPINEPHRINE-INJECTABLE GEL AS A PALLIATIVE TREATMENT FOR ACCESSIBLE SOLID TUMORS - A MULTICENTER PILOT-STUDY/, Otolaryngology and head and neck surgery, 118(4), 1998, pp. 496-503

Authors: BURRIS HA RAYMOND E AWADA A KUHN JG OROURKE TJ BRENTZEL J LYNCH W KING SYP BROWN TD VONHOFF DD
Citation: Ha. Burris et al., PHARMACOKINETIC AND PHASE-I STUDIES OF BREQUINAR (DUP-785, NSC-368390) IN COMBINATION WITH CISPLATIN IN PATIENTS WITH ADVANCED MALIGNANCIES, Investigational new drugs, 16(1), 1998, pp. 19-27

Authors: PEACOCK NW BURRIS HA DIERAS V SMITH L RODRIGUEZ GI ECKARDT JR JONES SF HARDY J HOHNEKER J BIGLEY J VONHOFF DD
Citation: Nw. Peacock et al., A PHASE-I TRIAL OF VINORELBINE IN COMBINATION WITH MITOXANTRONE IN PATIENTS WITH REFRACTORY SOLID TUMORS, Investigational new drugs, 16(1), 1998, pp. 37-43

Authors: AHMANN FR BURRIS HA NGUYEN B
Citation: Fr. Ahmann et al., THE EFFICACY OF GEMCITABINE IN CONTROLLING PAIN AND IMPROVING PERFORMANCE STATUS IN MEN WITH HORMONE-REFRACTORY PROSTATE-CANCER (HRPC), European journal of cancer, 33, 1997, pp. 148-148

Authors: BURRIS HA DIERAS V TUNCA M EARHART RH ECKARDT JR RODRIGUEZ GI SHAFFER DS FIELDS SM CAMPBELL E SCHAAF L KASUNIC D VONHOFF DD
Citation: Ha. Burris et al., PHASE-I STUDY WITH THE DNA SEQUENCE-SPECIFIC - AGENT ADOZELESIN, Anti-cancer drugs, 8(6), 1997, pp. 588-596

Authors: RAYMOND E BURRIS HA ROWINSKY EK ECKARDT JR RODRIGUEZ G SMITH L WEISS G VONHOFF DD
Citation: E. Raymond et al., PHASE-I STUDY OF DAILY TIMES 5 TOPOTECAN AND SINGLE INJECTION OF CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED NON-SMALL-CELL LUNG-CARCINOMA, Annals of oncology, 8(10), 1997, pp. 1003-1008

Authors: BURRIS HA MOORE MJ ANDERSEN J GREEN MR ROTHENBERG ML MADIANO MR CRIPPS MC PORTENOY RK STORNIOLO AM TARASSOFF P NELSON R DORR FA STEPHENS CD VANHOFF DD
Citation: Ha. Burris et al., IMPROVEMENTS IN SURVIVAL AND CLINICAL BENEFIT WITH GEMCITABINE AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED PANCREAS CANCER - A RANDOMIZED TRIAL, Journal of clinical oncology, 15(6), 1997, pp. 2403-2413

Authors: CREEMERS GJ GERRITS CJH ECKARDT JR SCHELLENS JHM BURRIS HA PLANTING AST RODRIGUEZ GI LOOS WJ HUDSON I BROOM C VERWEIJ J VONHOFF DD
Citation: Gj. Creemers et al., PHASE-I AND PHARMACOLOGICAL STUDY OF ORAL TOPOTECAN ADMINISTERED TWICE-DAILY FOR 21 DAYS TO ADULT PATIENTS WITH SOLID TUMORS, Journal of clinical oncology, 15(3), 1997, pp. 1087-1093

Authors: BENEDETTI JK BURRIS HA BALCERZAK SP MACDONALD JS
Citation: Jk. Benedetti et al., PHASE-II TRIAL OF TOPOTECAN IN ADVANCED GASTRIC-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Investigational new drugs, 15(3), 1997, pp. 261-264

Authors: JONES SF BURRIS HA
Citation: Sf. Jones et Ha. Burris, VINORELBINE - A NEW ANTINEOPLASTIC DRUG FOR THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER, The Annals of pharmacotherapy, 30(5), 1996, pp. 501-506

Authors: BURRIS HA
Citation: Ha. Burris, OPTIMAL USE OF DOCETAXEL (TAXOTERE(R)) - MAXIMIZING ITS POTENTIAL, Anti-cancer drugs, 7, 1996, pp. 25-28

Authors: ECKHARDT SG BURRIS HA ECKARDT JR WEISS G RODRIGUEZ G ROTHENBERG M RINALDI D BARRINGTON R KUHN JG MASUO K SUDO K ATSUMI R OGUMA T HIGASHI L FIELDS S SMETZER L VONHOFF DD
Citation: Sg. Eckhardt et al., A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THE ANGIOGENESIS INHIBITOR, TECOGALAN SODIUM, Annals of oncology, 7(5), 1996, pp. 491-496

Authors: ROTHENBERG ML MOORE MJ CRIPPS MC ANDERSEN JS PORTENOY RK BURRIS HA GREEN MR TARASSOFF PG BROWN TD CASPER ES STORNIOLO AM VONHOFF DD ALBERTS DS WOLFF R KELSEN DP KOCHA W HALLER DG MODIANOREVAH M MOORE M OKEN MM SCHILSKY RL SHAH A
Citation: Ml. Rothenberg et al., A PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH 5-FU-REFRACTORY PANCREAS CANCER, Annals of oncology, 7(4), 1996, pp. 347-353

Authors: ROTHENBERG ML ECKARDT JR KUHN JG BURRIS HA NELSON J HILSENBECK SG RODRIGUEZ GI THURMAN AM SMITH LS ECKHARDT SG WEISS GR ELFRING GL RINALDI DA SCHAAF LJ VONHOFF DD
Citation: Ml. Rothenberg et al., PHASE-II TRIAL OF IRINOTECAN IN PATIENTS WITH PROGRESSIVE OR RAPIDLY RECURRENT COLORECTAL-CANCER, Journal of clinical oncology, 14(4), 1996, pp. 1128-1135
Risultati: 1-25 | 26-50 | 51-54